Introduction
Gastric carcinoma primarily affects patients in the 50-to-70-year age group [1] [2] [3] . This tumor is uncommon before the fifth decade of life [1, 4] . Even though several studies have published reports of cases of adenocarcinoma in young adults [3, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , there was evidence of a molecular mutation in some of these patients. This suspicion motivated molecular studies that aimed to identify inherited mutations.
was no family history of cancer and her parents and sisters were healthy. At physical examination, she presented signs of anemia and weight loss (body mass index [BMI] 17); no pathological lymph nodes were palpable. Her pulmonary and cardiologic examinations were normal. Her abdomen was flat and painless on palpation, with a slightly enlarged liver, but without palpable masses; there was no ascites or epigastric mass, and intestinal sounds were normal. Rectal examination did not show any abnormalities. There were no clinical features of ataxia telangiectasia.
Laboratory tests revealed microcytic anemia (hemoglobin level, 8.8 g/dl), normal leucocytes, and increased platelets (427 000/mm 3 ). Total bilirubin and alkaline phosphatase levels were slightly increased. Albumin level was normal, at the lower limit [3, 8] . Urinalysis, liver function tests, and clotting studies were all normal. We investigated associated immunodefects, such as hypogammaglobulinemia and common variable immunodefficiency (CVID). However, all levels of immunoglobulins were normal.
An upper endoscopy with biopsy revealed, 35 cm from the upper incisors, an elevated lesion, friable, located in the posterior and right lateral walls of the esophagus and invading the cardia. From the retrovision of the stomach, extending for 3 cm, an elevated, ulcerated, and infiltrative lesion with active bleeding was seen. The conclusion was that there was a gastric Borrmann III tumor, with invasion of the distal esophagus and active bleeding. The lesion was biopsied and the histopathological diagnosis was a moderately differentiated adenocarcinoma.
For staging purposes, abdominal computed tomography was performed. It revealed parietal infiltration and thickening of the cardia, with extension to the small curvature of the stomach, where the lesion was elevated and lobulated, with a heterogeneous increase after the use of contrast. The liver was slightly augmented, with several hypoatenuated lesions, compatible with metastases, in both lobes, some presenting with central necrosis. There were irregular lesions in the spleen, involving the splenic capsule. There were enlarged lymph nodes at the periaortic level (Fig. 1) . The right ovary was enlarged and heterogeneous (Fig. 2) . Thoracic computed tomography was also performed, and showed several noncalcified pulmonary lesions, in both lungs, compatible with metastatic lesions (Fig. 3 ). There were no signs of enlarged mediastinal lymph nodes. Pleural thickening is also found at the right posterior base of the lung.
The patient's nutritional status was impaired due to the obstructive mass. A naso-enteral tube was inserted, guided by endoscopy.
Because the tumor presented at an advanced stage and with active bleeding, the patient was sent for ten radiotherapy sessions, with the purpose of hemostasis. After radiotherapy, the hemoglobin and hematocrit levels were stable and the patient was discharged and sent for outpatient sector follow-up. Palliative chemoradiotherapy was proposed.
The patient died within 4 months of the initial diagnosis.
Discussion
Tumors of the stomach usually affect patients after the fifth decade of life. It has been estimated that patients younger than 40 years of age represent between 2% and 8% of all patients with gastric carcinoma shows parietal infiltration and thickening of the cardia, extension to the small curvature of the stomach, enlarged liver, with several metastases, irregular splenic lesions, and enlarged lymph nodes at the periaortic level [11, 19] . This concept is so strong that younger patients presenting with characteristic symptoms usually have the correct diagnosis delayed [5] , and they are usually empirically treated before an upper endoscopy is performed. In the series of Theuer et al. [1] , upper endoscopy was used preoperatively in only 48% of young patients presenting with gastric cancer, as opposed to 97% of older patients, even though the symptoms and signs were similar in both groups. Moreover, young patients with gastric carcinoma had a preoperative histologic diagnosis made less frequently (59% vs 97%).
In the United States, the annual incidence of all malignant tumors in children is thought to be 9-12/100 000 [7, 20] . It is estimated that cancer of the gastrointestinal tract accounts for less than 5% of all pediatric neoplasms. Primary malignant tumors of the stomach are exceedingly rare in children, accounting for 0.05% of gastrointestinal tract tumors [7, 8] .
Malignant gastric tumors that affect children are mostly lymphomas and soft-tissue sarcomas. Carcinomas are extremely rare [7, 20] . Since 1960, about 20 cases have been reported in patients younger than 21 years of age [7] , and although there are some other reports in the medical literature, the number of patients is limited. Therefore we are unable to draw significant conclusions in terms of the prognosis, the biological behavior of the tumor [20] , the anatomical configuration, the usual locations, and the histology [21] .
The female : male ratio is 1 : 1 in patients younger than 21 years, as opposed to 1 : 2 in older patients [2, 5] . Tamura and Curtiss [9] found a predominance of young females.
A higher incidence of gastric cancer has been described in relatives of patients who have gastric carcinoma [9, 22, 23] . Such a relation was contested elsewhere [5] . Our patient did not have any family history of gastric cancer.
Although the average age of onset of cancer in families that presented with E-cadherin/CDH1 gene mutation was described as 38 years, a very early onset, at ages as young as 15 years, was also described [24] . Nevertheless, even though our patient presented with a very early onset of cancer, her family history did not fulfill the hereditary diffuse gastric cancer clinical criteria. Therefore, her probability of having an E-cadherin/ CDH1 gene mutation was very low, according to previous studies [25] . However, a blood sample was collected, with consent, and high-molecular genomic DNA was stored in order to check for possible congenital or hereditary disease. Our genomic analysis confirmed that the patient did not have the E-cadherin/CDH1 mutation.
Until recently, heterozygous DNA mismatch repair gene mutations were not described in relation to gastrointestinal tumors. Gallinger et al. [26] studied a family in which two children presented with homozygous germline DNA mismatch repair gene mutations and developed gastrointestinal tumors at very young ages. The 11-year-old boy presented with metastatic duodenal adenocarcinoma that arose in a tubulovillous adenoma, and his 9-year-old sister presented with malignant colon polyps. Their 6 year-old sister has not shown any evidence of malignancy. The family history was not consistent with the criteria for hereditary nonpolyposis colorectal cancer. However, the parents are first-degree cousins, and they remain cancer-free to date. The DNA sequence revealed that all three children had a germline homozygous MLH1 missense smutation.
In young patients, the signs and symptoms do not differ from those in the elderly. The most common symptoms on admission were epigastric pain and vomiting, followed by weight loss, weakness, anorexia, a palpable epigastric mass, and hematemesis [5, 7, 9, 14] . For tumors in the gastroesophageal junction the first presenting symptom was dysphagia [27] [28] [29] . Physical examination is usually not very conclusive. The most common physical signs are an epigastric mass or tenderness and signs of anemia or cachexia [5] . In other patients, the physical examination may be totally inconclusive [3] .
McNeer [5] reported that 275 of the 501 (54.9%) reviewed patients had distant metastases. Bloss et al. [3] also found that most patients presented with metastases at the time of diagnosis. They also described a high incidence of Krukenberg's tumors, in about 35% of females with evidence of metastases. Tamura and Curtiss [9] also found common and extensive involvement of the ovaries.
The most common histological type reported in most studies is the mucinous cell type, undifferentiated, with signet-ring cells [2, 8, 9, 14] , or poorly differentiated carcinoma [4] . The most common site of origin is the pyloric region [14, 30] . Other studies demonstrated that most tumors were located in the middle third of the stomach [4, 31] . Lauren [32] noted that diffuse cancers were more prevalent in younger patients and were associated with a poorer prognosis.
Some of the patients with adenocarcinoma presented with hypogammaglobulinemia or ataxia telangiectasia [8, 14, 20, 33] . It has been established that the death rate from malignancy in children with immunodeficiencies is much greater than that in the general age-matched population [14, 20, 34, 35] . We checked the serum levels of IgM, IgA, IgG, and IgE in our patient, and they were all normal; also, there were no signs of ataxia telangiectasia.
As for treatment, patients should be offered the same options, regardless of age group, at diagnosis. Surgery is the only treatment that may provide a cure for the disease. Adjuvant therapy is indicated, with complementary purposes, exclusively for advanced inoperable cases.
Prognosis is difficult to estimate. Some authors note that adenocarcinoma is rarely curable in young patients with symptomatic disease, and the prognosis is worse than it is in older patients. Some series have shown that gastric adenocarcinoma in the young is a highly lethal disease, with overall 5-year survival rates ranging from 2.6% to 20%. These studies emphasize that this tumor is rarely curable in young patients with symptomatic disease [1, [3] [4] [5] [9] [10] [11] . Delayed diagnosis is common in young patients in most reported cases, and the delay varies from 1 to 30 months (mean, 2.7 months) [3, 7, 21, 36] . Moreover, diffuse-type histology and poorly differentiated lesions are frequent in this age group [4, 32] . These factors could lead to more advanced cases on presentation and worse prognoses. However, other reports show that the prognosis is not necessarily worse than it is in older patients [5, 10] , or that it or may even be better [5, 37] .
In conclusion, gastric carcinoma in children is extremely rare. However, any persistent gastric symptoms or unexplained anemia in children should be carefully examined. We should consider and investigate the possibility of malignancy even in young patients, and the diagnosis should be made at earlier stages, to provide better chances for these patients to undergo curative treatment.
